PEMF Tissue Engineering Device with Dual-Frequency Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pulsed electromagnetic field (PEMF) treatments are limited to bone growth stimulation and do not effectively address injuries such as tendon and cartilage issues, like rotator cuff and Achilles tendon injuries, requiring a more comprehensive approach for tissue engineering.
Innovation Solution
A tissue engineering device that generates both high and low frequency PEMFs, with specific treatment regimens including high pulse frequency for tissue proliferation and low pulse frequency for tissue differentiation, allowing for adjustable treatment durations and schedules based on sensor data or counters, to enhance healing in musculoskeletal tissues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If single-frequency PEMF treatment is used, then bone growth stimulation is achieved, but treatment of other musculoskeletal tissues (tendon, cartilage) is limited
Solution Approach 1:
The PEMF treatment system is designed to provide multiple frequency modes (first frequency for bone tissue, second frequency for soft tissue) within a single device, enabling it to treat various musculoskeletal tissues including bone, tendon, ligament, and cartilage with optimized parameters for each tissue type
2Productivity
If high pulse frequency is applied, then tissue proliferation is enhanced, but tissue differentiation is insufficient
Solution Approach 1:
The treatment protocol employs periodic alternation between high pulse frequency (to stimulate tissue proliferation) and low pulse frequency (to promote tissue differentiation), with the transition timing dynamically adjusted based on sensor feedback regarding tissue healing progress
Solution Approach 2:
Sensors monitor the tissue healing status and provide feedback to the control system, which automatically adjusts the pulse frequency and treatment duration to optimize both proliferation and differentiation phases according to the actual tissue regeneration state
3Ease of operation
If fixed treatment duration is used, then treatment simplicity is maintained, but optimal healing outcomes cannot be achieved for varying tissue types
Solution Approach 1:
The treatment duration and frequency parameters are made dynamic rather than fixed, allowing the system to automatically adjust treatment protocols based on real-time sensor data about tissue healing progress, ensuring optimal parameters for each specific tissue type and healing stage
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach improves the efficacy of PEMF therapy beyond bone growth, effectively promoting healing in various musculoskeletal tissues by combining high frequency for proliferation and low frequency for differentiation, addressing the limitations of existing treatments.
Implementation Method 1
A processor (202) of the tissue engineering device (104) generates a command to generate high and low frequency pulsed electromagnetic fields (PEMFs)
Data Source
Figure 1
Figure 2
Figure 3A~3B
AI summary
A system and method for pulsed electromagnetic fields (PEMF) tissue engineering enhances musculoskeletal tissue stimulation. A tissue engineering device may include both low and high pulse frequency signal generation components that may alternatively drive one or more coils to generate PEMFs. These PEMFs may be applied to bone tissue, tendons, ligaments, and/or cartilage. A prescribed treatment regimen using the tissue engineering device may include a first period of time where a first pulse frequency is used in treatment that supports tissue proliferation followed by a second period of time where a second pulse frequency (less than the first pulse frequency) is used in treatment that supports tissue differentiation. A treatment regimen may also include, with the frequency characteristic, applying a slew rate to the pulse characteristics that is on the order of around 30 to 100 Tesla per second to drive tissue differentiation in a targeted manner.